Compass Therapeutics Inc. – Filings and Transcripts

NASDAQ: CMPX
Share price (6/2/26): $2.08
Market cap (6/2/26): $375 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Delaying amendment

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Biotechnology Value Fund L P

Anderman Jonathan

Anderman Jonathan

News Filter

Reports 2026 First Quarter Financial Results and Provides Corporate Update

Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients With Biliary Tract Cancer

Reports 2025 Financial Results and Provides Corporate Update

Provides Corporate Update

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission